MSI Methylation Sciences

About:

MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.

Website: http://methylationsciences.com

Top Investors: Quark Venture, Inventages Venture Capital Investment Inc., GrowthWorks Capital, Working Opportunity Fund

Description:

MSI Methylation Sciences Inc. operates as a biotechnology company. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in West Vancouver, Canada.

Total Funding Amount:

$48.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burnaby, British Columbia, Canada

Founded Date:

2007-01-01

Contact Email:

Info(AT)methylationsciences.com

Founders:

Barry Guld

Number of Employees:

51-100

Last Funding Date:

2016-10-06

IPO Status:

Private

Industries: